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NIRS nel Dominio delle Frequenze. 
Applicazioni Cliniche della Spetroscopia e 
Ossimetria del Cervello e del Muscolo 
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Why Near-Infrared Spectroscopy? 
 Non-invasive 
 Non-ionizing 
 Comfortable 
 Portable 
 Cost effective 
 Fast 
 Reliable 
 
 
 Real-time monitoring 
  of tissue oxygenation and hemodynamics 
 
Why Frequency Domain Near-Infrared 
Spectroscopy of Biological Tissues 
  
FD-NIRS separates absorption from scattering to obtain absolute 
values of hemoglobin concentration and tissue oxygen saturation 
Main NIRS parameters: 
 Oxygenated hemoglobin, [O2Hb] 
 Deoxygenated hemoglobin, [HHb] 
 Total hemoglobin, [tHb] = [O2Hb]+ [HHb] 
 Tissue oxygenation, SO2=[O2Hb]/[tHb] 
 
Frequency-Domain Tissue Oximeter 
(Developed at LFD-UIUC, Built by ISS Inc., Champaign, IL, USA). 
 
 
Modulation Frequency:   110 MHz 
 
Light sources:   8 laser diodes at 690 nm 
            8 laser diodes at 830 nm  
            (electronically multiplexed at 40Hz) 
Detectors:         2 photomultiplier tubes 
Multi distance Method 
Dual Sensor Probe 
(for bilateral frontal lobe measurements) 
Light source fibers Detector fiber 
Detector fibers:1 per channel (3 mm internal diameter) 
 
Source fibers:4 pairs of fibers (emitting 690 nm and 830 nm 
respectively) per channel 
 
Source-detector distance: Range 2-4 cm 
(multi-distance approach)   
Cerebral hemodynamic 
changes during voluntary hypoxia 
Altered Hemodynamic responses to breath holding  
in subject with severe cardiovascular disease. 
 
Decrease in [HHb]    
Increase in [O2Hb] 
Hemodynamic responses to breath holding in a  
healthy individual 
   
Increase in [O2Hb] 
Decrease in [HHb] 
   Healthy subject 
Cardiovascular patient  
Questions from the medical community: 
 
 Does the FD-NIRS and the multidistance approach 
probe the brain? 
 Which are the appropriate source-detector 
distances? 
 What proof can we give  that the findings are not 
influenced by the superficial tissues. 
 
Experimental approaches: 
 
 Brain vascular responsiveness to voluntary hypoxia 
with and without partial scalp ischemia. 
 Clamping of external and internal carotid arteries 
during neurovascular surgery 
 
Light source fibers Detector fiber 
Partial scalp ischemia induced by 
a head tourniquet 
a) 
Breath Holding Exercises on 11 healthy volunteers  
Without tourniquet With tourniquet 
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b) 
SDD  
1.08 cm-1.98 cm 
(Superficial Tissues) 
SDD  
1.98 cm-4.38 cm 
(Deep Tissues) 
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Clamping of External vs. Internal Carotid Artery  
in a Patient with Defective  Left to Right Brain Vascular Anastomotic 
Communication during Neurovascular Surgery 
NORMAL BRAIN ARTERIAL 
CIRCULATION 
External Carotid Artery Clamping 
 No change brain oxygenation and hemodynamics 
Internal Carotid Artery Clamping 
Significant changes in brain oxygenation and Hemodynamics  
Conclusions 
 
 Brain vascular response to hypoxia with and without partial scalp 
ischemia. 
 Clamping of external and internal carotids during neurovascular 
surgery 
 
Q. Does the FD-NIRS and multidistance approach probe the brain? 
A. By measuring light simultaneously at multiple distances we reduce 
the contribution of the superficial layer.  Optical properties of the 
superficial layer have no influence on time-of-flight.  
 
Q. Which are the appropriate source-detector distances? 
A. Light collected at 2-4 cm travels deeper into tissue and reaches 
the surface of the brain. 
 
Q. Is our method working? 
A. By looking at the details of brain hemodynamics during ischemia 
we differentiated spatial and temporal hemodynamic changes in 
the brain. 
 
 NIRS in Neurosurgery and ICU 
Post-Operative monitoring 
 
University of Illinois at Chicago Medical Center 
Chicago, Illinois 
Overall Trace  
Monitoring of Brain Oxygenation 
and Hemodynamics after Surgery 
Near-Infrared Brain Oximetry in Obstructive 
Sleep Apnea Syndrome 
 
 University of Illinois at Urbana Champaign 
Laboratory for Fluorescence Dynamics 
 
ISS Inc., Champaign, Illinois 
 
Carle Foundation Hospital-Sleep Center 
Urbana, Illinois 
 
University of Illinois at Chicago Medical Center 
Center of Sleep and Ventilatory Disorders 
 
Sleep apnea. The cessation of airflow through the nose and 
mouth during sleep that lasts for more than 10 seconds. 
 
Sleep apnea syndrome (SAS). At least 30 apneic episodes 
observed during a 7-hour sleep period. 
 
SAS types:  1. Obstructive (OSAS) 
                  2. Central 
                  3. Mixed 
 
 24% of males and 9% of females have 5 or more apneas per hour 
 
 12% of men and 5% of women present more severe forms (more  
   than 15 apneas per hour) 
 
 OSAS in middle age adults has been identified in approximately  
  4% of men and 2% in women 
 
 In elderly estimates range from 28% to 67% in men and 20% to  
  54% in women 
Sleep apnea: Risks 
 Social and professional impairment 
 
 Traffic and work accidents  
 
 Cardiovascular/pulmonary complications 
  a. Systemic hypertension 
  b. Pulmonary hypertension 
  c. Cardiac arrhythmias 
  d. Ischemic heart disease 
  e. Alteration of the vascular wall  
 
 Cerebrovascular complications 
  a. Neuropsychological dysfunction 
  b. Cognitive deficits  
  c. Transient ischemic attacks 
  d. Strokes 
 
 Death 
POLYSOMNOGRAPHY (sleep study) 
 
Monitoring of: 
 Snoring 
 Respiratory effort 
 Naso-oral airflow 
Recordings of: 
 Electrocardiogram (EKG) 
 Electroencephalogram (EEG) 
 Bilateral electro-oculogram (EOG) 
 Bilateral anterior tibialis Electromyogram (EMG) 
 Submental electromyogram (EMG) 
 Arterial oximetry 
 
But………it does not provide the clinician with information  
on cerebral oxygenation and hemodynamics,                
which are important parameters one wishes to determine. 
 
Measurement protocol 
 Breath holding exercises 
• 3-4 min baseline 
• breath holding at FRC with resumption of 
breathing (3-5 times) 
• 5-10 min baseline recovery 
• Repetition of breath holding and 
resumption of breathing (3-5 times) 
 
 NIRS measurements during sleep 
 
Changes in cerebral hemodynamics 
with respect to baseline values 
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BREATH  HOLDING
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DIURNAL  NAPPING
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 Capillaries are the "heart" of the circulatory system, all 
 the action is in the capillaries, and all other blood vessels 
merely assist them. 
 
 The blood flow across the capillary bed is regulated by a sphincter 
muscle on the arteriole side.  Whenever there is little need to 
supply blood to a given capillary bed, the sphincter closes and blood 
bypasses the capillary bed via an arterio-venal shunt. 
 
 The cerebrovascular response to hypoxia (decreased O2) and 
hypercapnia (increased CO2) is vasodilation  and opening of the 
capillary bed. 
 
 
9 subjects (3716 years) 
52 breath holdings 
(25 11 s) 
12 subjects (3810 years) 
72 breath holdings 
(30 19 s) 
8 subjects (4916 years) 
58 breath holdings 
(18 7 s) 
Changes in total hemoglobin concentration 
during breath holding  
Voluntary Breath Holding Duration, s 
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1 - area of tHb changes observed for control subjects                       
2 - area of tHb changes observed for OSAS subjects  
0.60.9 22.315.8 OSAS 
(8 subjects/ 8sessions/ 26 breath holds) 
2.92.3 42.024.1 Controls  
(8 subjects/ 8sessions/ 31 breath holds) 
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Changes in brain tissue total hemoglobin concentration 
(changes in cerebral blood volume) 
        1 - area of changes in control non-snorers 
        2 - area of changes in OSA sufferers 
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Changes in brain hemodynamics and tissue oxygenation during sleep  
(a,b) control subject, (c,d) OSA subject  
 
Arterial blood oxygen saturation (SaO2 ) is measured via pulse oximetry. 
Breathing is monitored via a strain gauge around the chest. 
Brain tissue oxygenation (SO2) and tissue hemoglobin oxygen saturation are measured by NIRS 
 
Right Frontal Lobe:  Oxy-Hb (Red) 
  Deoxy-Hb (Blue) 
Left Frontal Lobe:  Oxy-Hb (Light Blue) 
  Deoxy-Hb (Green) 
Breathing (Black) 
Pulse (Gray) 
Breath holding 
Time (sec) 
Sleep Apnea 
Time (sec) 
OSA 
sufferer  
Control  
Hemodynamic responses to hypoxia 
Characterization of the subjects based on changes in [O2Hb] and [HHb] due to 
breathing during sleep 
1 - severe OSA subjects;    
2 - youngest OSA subjects  (29 & 44 years old) 
3 - snorer with a family history of OSA ; 
4 - oldest snorer (73 years old);  
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We track the intra-hemispheric temporal correlations to observe anti-correlation or 
anti-phase behavior with respect to the changes in oxy- and deoxy-Hb, which is 
displayed as an angle of 180 degrees. 
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Healthy Control: six hours of sleep in histogram [column 1] 
OSAS: three hours of sleep with multiple apneic events [column 2, red box] 
CPAP: three hours of sleep in OSAS subject with CPAP [column 3, red box] 
(Split PSG study: OSAS subject is diagnosed and fitted with CPAP for apneic event reduction therapy.) 
Analysis Schemes: 
 
The Hilbert Transform provides two types of temporal information: (1) we can track 
the correlations in time and (2) we can analyze all the points in time as a histogram.  
The figures show the histograms of the inter-hemispheric oxygenation (Ox%)  
Conclusion 
 NIRS provides non-invasive, transcranial, real-time 
measurements of cerebral oxygenation and hemo-
dynamics. 
 NIRS gives direct information on cerebrovascular 
autoregulation. 
 NIRS may provide a cost-effective screening for 
cerebrovascular morbidity in OSAS sufferers. 
 NIRS may be associated with the standard 
overnight polysomnography to monitor brain 
vascular responsiveness to hypoxia in OSAS. 
Age correlated changes in 
cerebral hemodynamics 
assessed by near-infrared 
spectroscopy 
 
Changes in oxy- and deoxy-hemoglobin concentrations assessed 
in a control non-snorer during breath holding 
 
-1.5
0.0
1.5
3.0
0 8 16 24
Breath holding duration, s
D
[O
2
H
b
] 
an
d
 D
[H
H
b
],
 m
m
o
l/
L
D[O2Hb]
D[HHb]
Analyzed changes in cerebral hemodynamic parameters 
on the 12th second of breath holding and mean changes 
during the 8th – 16th seconds (shaded area). 
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Decreases in D[O2Hb], D[tHb], and  DSO2, and an increase in  
D[HHb] during hypoxic episodes were observed in older subjects.  
NIRS in Attention Deficit Hyperactivity 
Disorder (ADD/ADHD) 
 
 
Collaborative Project 
 
University of Illinois at Urbana-Champaign 
Laboratory for Fluorescence Dynamics 
 
Carle Clinic, Urbana Illinois 
UIUC College of Medicine, Department of 
Pediatrics 
 
The University of Texas 
Southwestern Medical Center at Dallas 
Department of Pediatrics 
ADHD - Attention Deficit Hyperactivity 
Disorder 
The most common psychiatric developmental disorder in USA 
Qualitative Diagnosis 
•  Hyperactive type: “always on the go” 
•  Inattentive type: “struggle to stay focus” 
•  Mixed type: the most common 
•  Symptoms must be constant and across settings 
 
Hypoperfusion hypothesis 
•  abnormal distribution of regional Cerebral Blood Flow (rCBF) 
•  frontal lobes, frontal-striatal-cerebellar circuits 
•  volumetric evaluation: PET, MRI, CT 
 
Methylphenidate 
•  stimulates the release/block of reuptake of 
  extracellular dopamine in the synaptic cleft. 
•  reduces inattentive, impulsive, and hyperactive symptoms. 
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Potential Diagnostic Screening 
7 years old control child 
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7 years old ADHD hyperactive child 
Tapping exercise, Right hand. Showing 
regional hypoperfusion? 
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Final Remarks 
• NIRS provides non-invasive, transcranial, real-time 
measurements of cerebral oxygenation and hemodynamics. 
• NIRS can measure absolute values of the concentrations of 
[HbO2], [HHb], and [tHb] and tissue oxygenation. 
 
• NIRS aims to study specific hemodynamic patterns in ADHD: 
• detect hypoperfusion with functional NIRS. 
• detect brain development anomaly in populations of young 
children. 
• assess brain segregation in the frontal lobes in ADHD. 
• contribute to ADHD diagnosis and pharmacological 
treatment. 
• More synchronous locations for measurements are needed. 
Motor cortex activation 
Collaborative project 
 
University of Illinois at Urbana-Champaign 
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Tufts University, Medford MA 
Department of Electrical Engineering and computer Science 
Plots of Source-Detector Pairs by DPF 
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Simultaneous 
measurement of fMRI and 
NIRS of brain function 
Collaborative Project 
 
University of Illinois at Urbana-Champaign 
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Simultaneous Multi-source Frequency-domain NIRS 
and BOLD fMRI signals during motor functional 
activation in humans:  Collocation of signals 
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The Absorption and Scattering of Intensity  
Modulated NIR Light is Measured in the 
Tissue Beneath the Sensor 
Light detector position 
Light source position 
Sample 
source 
detector 
Peripheral Vascular 
Disease 
 
ISS Inc. 
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UIUC College of Medicine, VA Hospital, Danville, Illinois 
 
The University of Texas 
Southwestern Medical Center at Dallas, Department of VA 
 
Policlinico Monteluce, University of Perugia, Italy 
 
Peripheral Vascular Disease (PVD) is a 
chronic condition characterized by poor 
circulation in the extremities 
 
 PVD manifests as insufficient tissue perfusion 
 
 Blocked blood flow can cause pain and numbness.  
It can result in dangerously low delivery of 
Nutrients and Oxygen to tissues especially in the 
foot and lower leg 
 
 Affects 12-14% of General Population and >20% 
of people over 75 
 
 Over 100,000 Surgical Interventions Per Year 
 
 Early Detection, Monitoring, and Treatment May 
Improve Quality of Life and Reduce Surgeries 
The Human Clinical Trial for PVD Assessment 
 
 
Patient Groups 
 Healthy Controls   17 Subjects 
 At Risk-    29 Subjects 
 Intermittent Claudication  27 Subjects 
 Rest Pain     7 Subjects 
 Dialysis   15 Subjects 
 
Protocol 
 Oximeter Monitoring Of Both Calves Simultaneously 
  
 Stand 
 Walk On Treadmill, 2 MPH at 3% Incline 
 Stand 
Pre And Post Exercise ABI (Ankle Brachial Index) Also Measured 
Tissue Oxygenation at Rest 
(Average and Standard 
Deviation)  
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Conclusion: There is a correlation between saturation attained during 
exercise and clinical condition. 
the step function in the shaded areas indicates exercise load (on a stationary bicycle) 
patients affected by peripheral vascular disease show: 
  larger desaturation during exercise 
  longer recovery time after exercise 
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Typical hemoglobin saturation traces 
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Conclusion:  There is a strong correlation between saturation 
recovery time after exercise and clinical condition 
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Hemodynamic Analysis Case Study  
Saturation (%)  THC (µM)  
[Oxy-Hb] (µM)  [Deoxy-Hb] (µM)  
Left Calf     
Scheduled For Left Side Femoral Artery Bypass 
Angiogram Verified Left Femoral Occlusion 
Summary and Conclusions 
 
 
Baseline Saturation, Exercise Induced De-Saturation, 
and Post Exercise Saturation Recovery Time all 
Correlate with Clinical Condition 
 
Exercise Induced Saturation measurements may be 
effective for PVD assessment 
 
Hemodynamic Analysis of Oximetry Data may provide 
Diagnostic Information in addition to PVD Assessment 
ISS  Imagent™  
We are able to create functional maps of the tissue 
Maps of O2Hb during a venous occlusion of 3 minutes duration 
cuff 
subject with PVD, 
left leg 
subject with mild 
PVD, right leg 
normal subject, 
right leg 
video runs 3 times 
faster than real time: 
10s start of occlusion 
70s end of occlusion 
color scale in µM 
Why Near-Infrared Spectroscopy 
and Imaging of Tissues? 
 Real-time monitoring of tissue oxygenation and 
hemodynamics 
 Non-invasive 
 Portable 
 Cost effective 
 Fast 
 Reliable 
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